Maitake mushroom (Grifola frondosa) extract induces ovulation in patients with polycystic ovary syndrome: A possible monotherapy and a combination therapy after failure with first-line clomiphene citrate

Journal of Alternative and Complementary Medicine

Volumn 16, Issue 12, 2010, Pages 1295-1299

  Chen, Jui Tung ^a   Tominaga, Kunihiko ^b   Sato, Yoshiaki ^c   Anzai, Hideo ^d   Matsuoka, Ryo ^e  

^a JT Chen Clinic   (Japan)

^b Department of Gynecology   (Japan)

^c Sophia Ladies Clinic   (Japan)

^d Anzai and Associates   (United States)

^e Odaira Memorial Tokyo Hitachi Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE CITRATE; GRIFOLA FRONDOSA EXTRACT; IMMUNOMODULATING AGENT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TREATMENT FAILURE; ECHOGRAPHY; FEMALE; GRIFOLA FRONDOSA; HUMAN; INSULIN RESISTANCE; JAPAN; MAITAKE MUSHROOM; MEDICINAL PLANT; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; MUSHROOM; OVARY POLYCYSTIC DISEASE; OVULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

ADULT; BIOLOGICAL PRODUCTS; CLOMIPHENE; DRUG THERAPY, COMBINATION; FEMALE; FERTILITY AGENTS, FEMALE; GRIFOLA; HUMANS; HYPOGLYCEMIC AGENTS; INFERTILITY, FEMALE; INSULIN RESISTANCE; OVULATION; POLYCYSTIC OVARY SYNDROME; TREATMENT FAILURE; YOUNG ADULT;

EID: 78650080974     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2009.0696     Document Type: Article

References (32)

1. Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745-2749.
2. ESHRE/ASRM Working Group. Revised 2003 consensus on diagnosis criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod 2004;19:41-47.
3. Azziz R. Controversy in clinical endocrinology: Diagnosis of polycystic ovary syndrome. The Rotterdam criteria are premature. J Clin Endocrinol Metab 2006;91:781-785.
4. Ng EHY, Ho PC. Polycystic ovary syndrome in Asian women. Semin Reprod Med 2008;26:14-21.
5. Fertility and Endocrinology Committee of Japan Society of Obstetrics and Gynecology. A consensus working group report on new diagnostic criteria of polycystic ovary syndrome 2006 in Japan [in Japanese]. Acta Obstet Gynaecol Jpn 2007; 59:868-886.
6. Imani B, Eijkemans MJ, te Velde ER, et al. Predictors of chances to convince in ovulatory patients during clomifene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 1999;84:1617-1622
7. The ESHRE Capri Workshop. Female infertility: Treatment optionsforcomplicated cases. Hum Reprod1997;12:1191-1196.
8. Velazquez EM, Mendoza S, Hamer T, et al. Metformin therapy in polycystic ovary syndrome reduces hyper-insulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 1994;43:647-654.
9. Bailey CS, Turner RC. Metformin drug therapy. NEJM 1996;334:574-579.
10. Lord LM, Flight IHK, Norman RJ. Metformin on polycystic ovary syndrome: A systematic review and metaanalysis. BMJ 2003;327:951-954.
11. Fullerton SA, Samadi AA, Tortorelis DG, et al. Induction of apoptosis in human prostatic cancer cells with beta-glucan (Maitake mushroom polysaccharide). Mol Urol 2000;4:7-13.
12. Kabir Y, Yamaguchi M, Kimura S. Effect of Shiitake (Lenti-nus edodes) and Maitake (Grifola frondosa) mushrooms on blood pressure and plasma lipids of spontaneously hypertensive rats. J Nutr Sci Vitaminol 1987;33:341-346.
13. Adachi K, Nanba H, Otsuka M, et al. Blood pressure-lowering activity present in the fruit body of Grifola frondosa (Maitake). Chem Pharm Bull 1988;36:1000-1006.
14. Kubo K, Aoki H, Nanba H. Anti-diabetic activity present in the fruit body of Grifola frondosa (Maitake). Biol Pharm Bull 1994;17:1106-1110.
15. Horio H, Ohtsuru M. Effects of administration of Grifola frondosa on glucose tolerance and glucosuria in rats with experimental diabetes. J Jpn Soc Nutr Food Sci 1995;48:299-305.
16. Konno S, Tortorelis G, Fullerton SA, et al. A possible hy-poglycemic effect of Maitake mushroom on type 2 diabetes patients. Diabetic Med 2001;18:1010. (Pubitemid 34042943)
17. Fukushima M, Ohashi T, Fujiwara Y, et al. Cholesterol-lowering effects of Maitake (Grifola frondosa) fiber, shiitake (Lentinus edodes) fiber, and enokitake (Flammulina velutipes) fiber in rats. Exp Biol Med 2001;226:758-765.
18. Manohar V, Talpur NA, Echard BW, et al. Effects of a water-soluble extract of Maitake mushroom on circulating glucose/insulin concentrations in KK mice. Diabetes Obesity Metab 2002;4:43-48.
19. Talpur NA, Echard BW, Fan AY, et al. Antihypertensive and metabolic effects of whole Maitake mushroom powder and its fractions in two rat strains. Mol Cell Biochem 2002;237: 129-136.
20. Talpur N, Echard B, Dadgar A, et al. Effects of Maitake mushroom fractions on blood pressure of Zucker fatty rats. Res Commun Mol Pathol Pharmacol 2002;112:68-82.
21. Talpur N, Echard BW, Yasmin T, et al. Effects of niacin-bound chromium, Maitake mushroom fraction SX and hy-droxycitric acid on the metabolic syndrome in aged diabetic Zucker fatty rats. Mol Cell Biochem 2003;252:369-377.
22. Preuss HG, Echard B, Bagchi D, et al. Enhanced insulin-hypoglycemic activity in rats consuming a specific glycopro-tein extracted from Maitake mushroom. Mol Cell Biochem 2007;306:105-113.
23. Balen AH, Laven JS, Tan SL, et al. Ultrasound assessment of the polycystic ovary: International consensus definitions. Hum Reprod Update 2003;9:505-514.
24. Carmina E, Koyama T, Chang L, et al. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Ob-stet Gynecol 1992;167:1807-1812.
25. Azziz R, Ehrmann D, Legro RS, et al. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab 2001;86:1626-1632.
26. Ghazeeri G, Kutteh WH, Bryer-Ash M, et al. Effect of ro-siglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome. Fertil Steril 2003;79:562-566.
27. Brettenthaler N, De Geyeter C, Huber PR, et al. Effect of the insulin sensitizer pioglitazone on insulin resistance, hyper-androgenism, and ovulatory dysfunction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004; 89:3835-3840.
28. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovula-tion in the polycystic ovary syndrome. NEJM 1998;338:1876-1880.
29. Nestler JE, Jakubowicz DJ, Reamer P, et al. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. NEJM 1999;340:1314-1320.
30. Moll E, Bossuyt PM, Korevaar JC, et al. Effect of clomiphene citrate plus metformin and clomiphene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: Randomized double blind clinical trial. BMJ 2006;332:1485-1489.
31. Palomba S, Orio F Jr, Falbo A, et al. Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese an-ovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:4068-4074.
32. Legro RS, Barnhart HX, Schlaff WD, et al. Clomifene, met-formin, or both for infertility in the polycystic ovary syndrome. NEJM 2007;356:551-566.